Morinaga & Co Ltd operates in the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Morinaga & Co Ltd with three other
bakery and confectionary companies in Asia:
Nakamuraya Co., Ltd.
sales of 41.36 billion Japanese Yen [US$372.63 million]
of which 74%
was Confectionery Business),
Imuraya Group Company Limited
(45.06 billion Japanese Yen [US$406.01 million]
of which 88%
was Distribution Business), and
GlaxoSmithKline Consumer Healthcare Limited
based in India
(43.17 billion Indian Rupees [US$626.76 million]
of which 100%
Morinaga & Co Ltd reported sales of ¥205.02 billion (US$1.85 billion)
March of 2018.
increase of 2.8%
versus 2017, when the company's sales were ¥199.48 billion.
Sales at Morinaga & Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 34%).
Sales of Food Products saw an increase
3.3% in 2018, from
¥189.61 billion to ¥195.79 billion.
Not all segments of Morinaga & Co Ltd experienced an increase in sales in 2018:
sales of Real Estate and Services fell 17.1% to ¥2.04 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).
Morinaga & Co Ltd also experienced decreases in sales in
Wholesale Food and Restaurant (down 2.5% to ¥6.69 billion)
Other (down 7.4% to ¥511.00 million)